INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. on September 12, 2025, covering an event that occurred on September 8, 2025. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol "IVF".
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The specific financial transaction reported is as follows:
- Capital Raised: $200,000 in cash.
- Securities Issued: 200 shares of Series C-2 Convertible Preferred Stock.
- Stated Value: $200,000 aggregate stated value.
- Conversion Price Adjustment: The exercise adjusted the conversion price on the C-2 Preferred to $0.7362 per share.
Material Changes
The material change reported is the unregistered sale of equity securities. An institutional investor and existing holder exercised an Additional Investment Right under a Securities Purchase Agreement (originally dated January 3, 2024, with a joinder agreement on October 11, 2024) to acquire the aforementioned preferred shares. This transaction was conducted without registration under the Securities Act, relying on exemptions under Section 4(a)(2) and/or Rule 506.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure regarding the unregistered nature of the securities sale. No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the impact of the new $0.7362 conversion price on existing dilution metrics for common shareholders.
- Confirm the identity of the institutional investor exercising the Additional Investment Right.
- Review the July 1, 2025 Form 8-K (Item 1.01) referenced in this filing for additional context on the Securities Purchase Agreement.
- Monitor future filings for the actual conversion of these preferred shares into common stock.